Madrid, Spain: The combined administration of THC
and the pharmaceutical agent temozolomide (TMZ) demonstrates strong
anti-cancer activity in brain tumors resistant to conventional
anti-cancer treatments, according to preclinical data published online in the journal Molecular Cancer Therapeutics.
Investigators at Complutense University in Spain assessed the anti-tumor activity of the cannabinoids THC and CBD (cannabidiol) in glioma xenografts (tissue grafts).
Authors
reported that the administration of THC in combination with TMZ (the
benchmark agent for the management of glioblastoma) "enhanced autophagy"
(programmed cell death) in malignant tissue. The combined
administration of THC, CBD, and TMZ "remarkably reduce[d] the growth of
glioma xenografts ... [and] produced a strong antitumoral action in both
TMZ-sensitive and TMZ-resistant tumors."........
You can read the full story here
This post was brought to you by Norml.org
No comments:
Post a Comment